VXRT News and Press, Vaxart Inc. From 02/04/20

Gainers:  Myomo (NYSEMKT: MYO )  +437% . More news on: Myomo, Inc., Allot Ltd., Phibro Animal Health Corporation, Stocks on the move, , Read more ...

Gainers: OpGen (NASDAQ: OPGN ) +49% . More news on: OpGen, Inc., Insmed Incorporated, Artelo Biosciences, Inc., Stocks on the move, , Read more ...

Penny Stocks To Watch To Start The Week Penny stocks represent a high risk and high reward investment option for people. Though these stocks are volatile by nature. That’s initially based on the fact that they trade for less than $5. So, there is always the possibility of making signi...

5 Penny Stocks to Watch Right Now When it comes to stock market investing, there is always an element of risk. This is true no matter how big a company one is investing in. With the case of penny stocks , that risk is even higher. The main reason is that these low-priced stocks are very volat...

SOUTH SAN FRANCISCO, Calif., Jan. 31, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NasdaqGS:  VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines administered by tablet rather than by injection, announced today that it has initiated a program to develop a coron...

Markets are trying to recover this morning after one of the biggest dips it’s seen since October. One of the biggest contributing factors has been the coronavirus. The death toll continues to rise as China makes attempts to curb the global risks of creating a pandemic. The majority of dea...

SOUTH SAN FRANCISCO, Calif., Jan. 22, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. (VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines administered by tablet rather than by injection, announced today that the results from its H1 influenza oral tablet vaccine challen...

Vaxart (NASDAQ: VXRT ): Q3 GAAP EPS of -$0.32 beats by $0.03 . Revenue of $0.45M (+60.7% Y/Y) beats by $0.01M . Press Release More news on: Vaxart, Inc., Earnings news and commentary, Healthcare stocks news, ,

- $9 million Underwritten Public Offering Closed - - Oral Bivalent Norovirus Vaccine Meets Primary and Secondary Endpoints in Phase 1b Study - SOUTH SAN FRANCISCO, Calif., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Vaxart, Inc., a clinical-stage biotechnology company developing oral recombin...

Noteworthy events during the week of November 10 - 16 for healthcare investors. More news on: Ocular Therapeutix, Inc., Y-mAbs Therapeutics, Inc., Amarin Corporation plc, Healthcare stocks news, , Read more ...